Tentative deal reached with Purdue Pharma

Purdue Pharma reaches tentative deal in federal, state opioid lawsuits

Tentative deal reached with Purdue PharmaThe tragedy of a deal like the one being offered (i.e. Tentative deal reached with Purdue Pharma) by the Sacklers is that the family has long since transferred much of its interests to an entity named Rhodes Pharmaceuticals in Coventry, RI. Rhodes was set up in 2007 to sell generic opioids and provide a potential refuge for family interests. Rhodes in turn has made distributions to The Rosebay Medical Company and the Beacon Company owned by trusts set up for the Sackler. As Purdue has faded Rhodes has grown. Also that Forbes estimates the families fortune to exceed $13 billion.

Still you ask, “Why do some people who do bad things, seem to never get caught and punished like they deserve?”

Yet in the cold light of day you answer the very opportunity to rightfully punish wrong-doing with cowardice to face down those bad people. The thought makes you cringe with fear and clamor to take their first offer, even though it would barely touch their wealth gleaned from more than 200,000 American deaths and counting!”

Shame on us al!, as the answer lies in the very question. The answer is us and it is them. The former, “our” fear and cowardice. The latter, “their” cleverness, brilliance, and toughness.  Anything to escape the glare of the light shinning on them and the resources to buy the best protection available, legal or otherwise to keep them safe from it.

Will we take them on now or latter? If we let them off the hook now, do we really think the game is over and that’s the last that will be hear of the Sacklers? Maybe in our generation or lifetime, but then what horror do we leave future generations as they gather ever more resources and tricks to evade that light. Will it take a million more opioid deaths? Two million?

The Sackler family WILL pay dearly…someday! It could happen now, or over the next two or three or five years if the battle is enjoined and  their vicious crimes eventually squeeze them into a smaller and smaller space until there IS no space except the cell of a Federal prison.

Relevant question? How many fewer children would have been abused if the Catholic Church or the Boy Scouts of America had been “outed” 30, or 100, or 1,000 years ago? They became institutionalized, pits” of abuse, dishonesty and ruinous behavior, with tremendous, collective resources to protect them.

Of course the Sackler’s want the same. If this offer is rejected there will be other much more generous ones. Of course there will be! Even this offer acknowledges their guilt, their murder, their total complicity in actually lowering the life expectancy of Americans for the first time since they started counting.

Tentative deal reached with Purdue Pharma
Rhodes Pharmaceuticals L.P. Logo (PRNewsFoto/Rhodes Pharmaceuticals L.P.)

Over time, Rhodes has made distributions to The Rosebay Medical Company and the Beacon Company owned by trusts set up for the Sacklers. As Purdue has faded Rhodes has grown. Forbes estimates the families fortune to exceed $13 billion.

We all, even the Sacklers, know that you DO reap what you sow. Its just that the really smart and clever ones, think they can get away with whatever their evil brew may be, and for some length of time, sometimes they do.

We often see it play out in others. We even say the words, “What Goes Around Comes Around!” We say those words over and over in regard to other people. And its true…eventually, depending on how clever, smart and good a liar, someone is.

The Catholic Church is the best example of all.How far back do YOU think that priests have been abusing children? Right! How could that be? It can, because they are collectively brilliant, extraordinarily deceptive, have unlimited resources monetarily, politically and otherwise, and are exceptional liars. As such ,they are only now beginning to feel the fences closing in at an accelerating pace.

The Sackler’s represent an evil that can potentially be with us in our midst for a very, long time. It could be decades or more depending on how meekly we take them on now.

Is this the time, when they are on the veritable ropes, to let fear of the short term give our defenders weak knees and allow the vicious bastards to slink off and lay low. At best it will only be until they deem the time ripe to strike again?

I hope like hell the answer is NO!

~ Rob

Purdue Pharma reaches tentative deal in federal, state opioid lawsuits

September 11 at 1:50 PM

Tentative deal reached with Purdue PharmaPurdue Pharma, manufacturer of the blockbuster painkiller OxyContin, reached a tentative settlement Wednesday with 23 states and more than 2,000 cities and counties that sued the company over its role in the opioid crisis, according to attorneys involved in the deal.

The executive committee of lawyers representing cities, counties and other groups in a federal lawsuit against Purdue and other drug companies is recommending the deal be accepted. But more than half the state attorneys general in the nation balked, saying they planned to continue pursuing the company and its owners, the Sackler family.

Sacklers’ would relinquish control

Under terms of a plan negotiated for months, the Sacklers would relinquish control of Stamford, Conn.-based Purdue Pharma and admit no wrongdoing. The company would declare bankruptcy and be resurrected as a trust whose main purpose would be producing medications to combat the opioid epidemic.

If the deal becomes final, it would be the first comprehensive settlement in the broad effort to hold drug companies accountable for their role in the opioid epidemic. To date, Purdue has also settled with one state, Oklahoma, for $270 million, and won a victory when a North Dakota judge threw out that state’s case against the company.

Purdue pleaded guilty to criminal charges

The deal also would mark the demise of Purdue as a private company widely blamed for its role in driving the prescription opioid epidemic in the late 1990s and the first years of this century. In 2007, Purdue and three of its executives pleaded guilty to criminal charges of misleading doctors and the public about the safety of OxyContin and paid a $635 million fine.

The prescription drug epidemic has taken more than 200,000 lives via overdoses since 1999, according to federal statistics. An additional 200,000 deaths are blamed on overdoses from heroin and illegal fentanyl smuggled into the country from China and Mexico.

Some states are openly opposing the deal

On Wednesday, the divide over the settlement broke down largely along party lines, with most Republican state attorneys general in favor of it and Democrats largely opposed. The states openly opposing the deal — including California, Connecticut, North Carolina, New York, New Jersey, Maryland and Pennsylvania — could take their objections to bankruptcy court and tie up the proceedings for years, some experts said.

“These people are among the most responsible for the trail of death and destruction the opioid epidemic has left in its wake,” said North Carolina Attorney General Josh Stein, who plans to sue the Sacklers personally.

Tentative deal reached with Purdue Pharma

Slap in the face!

“This apparent settlement is a slap in the face to everyone who has had to bury a loved one due to this family’s destruction and greed,” said Pennsylvania Attorney General Josh Shapiro. “It allows the Sackler family to walk away billionaires and admit no wrongdoing.”

But Republican attorneys general, Dave Yost of Ohio and Ken Paxton of Texas, backed the agreement.

“The proposed settlement with Purdue provides the greatest certainty for all Ohioans to receive relief as quickly as possible in light of rumored bankruptcy,” said Yost spokeswoman Bethany McCorkle.

In addition to 23 states, four territories supported the deal. Paxton said it would “secure billions in funding to address opioid addiction across the nation, and permanently remove the Sackler family from the pharmaceutical industry.”

In a statement, Purdue said it “continues to work with all plaintiffs on reaching a comprehensive resolution to its opioid litigation that will deliver billions of dollars and vital opioid overdose rescue medicines to communities across the country impacted by the opioid crisis.”

Mortimer D. Sackler and Raymond Sackler families issued a statement

Tentative deal reached with Purdue Pharma
Mortimer Sackler

Members of the Mortimer D. Sackler and Raymond Sackler families issued a statement saying that “the family supports working toward a global resolution that directs resources to the patients, families and communities across the country who are suffering and need assistance. This is the most effective way to address the urgency of the current public health crisis and to fund real solutions, not endless litigation.”

The deal was said to be worth $10 billion to $12 billion, including a guarantee of $3 billion payment from the Sacklers over seven years. That could be financed at least in part by the sale of the family’s international drug conglomerate, Mundipharma, according to an analysis of the deal reviewed by The Washington Post. If the Sacklers earn more than $3 billion from that sale, part of it would go to the plaintiffs as well, according to a provision of the settlement.

The proposal was as good as they could get

The federal plaintiffs and many attorneys general believed the proposal was as good as they could get. The lawyers for the cities and counties agreed to recommend they “move forward in support of the current proposal, subject to satisfactory documentation of the essential terms and final documents,” said Paul J. Hanly Jr., Paul T. Farrell Jr. and Joseph F. Rice, three of the leaders of that group. “We feel good progress has and will continue to be made.”

But some states objected that the Sacklers were not contributing enough cash from their personal fortunes, built largely on the sale of OxyContin and taken out of the company in recent years, according to court papers filed by some states.

Another major concern is that the deal relies in significant measure on the assumed value of Purdue’s assets and the sale of its global drug company. States opposing it fear that these values may be overestimated and that some of the settlement money may never materialize.

The $10 to $12 billion figures are vaporous

“The $10 to $12 billion figures are vaporous,” said Maryland Attorney General Brian E. Frosh (D). “I have not seen a deal that would yield anywhere close to those kinds of returns.”

Still pending is the mammoth federal case in Cleveland against other drug manufacturers, distributors and retail pharmacy chains, known as a “multidistrict litigation” or MDL. In that case, the lawsuits from cities, counties, Indian tribes, hospitals and other groups have been consolidated. Judge Dan Aaron Polster has presided over that litigation, urging the parties to settle before trial so that money can be funneled quickly into drug treatment, emergency care, law enforcement and other local needs.

The federal trial is scheduled to begin in mid-October with two test cases, Cuyahoga and Summit counties, as the first plaintiffs. Meanwhile, the more than 40 lawsuits against drug companies are wending their way through state courts. Purdue would be eliminated from those cases where a settlement is finalized. A growing number of states also have sued the Sackler family personally.

Won a $572 million verdict against Johnson & Johnson

Oklahoma, the first state to go to trial, last month won a $572 million verdict against Johnson & Johnson. In addition to settling with Purdue before the trial, it reached an agreement with Teva Pharmaceuticals, a generic drugmaker, for $85 million.

In another development Wednesday, Polster certified a plan that could allow every municipality in the nation to share in the proceeds if a settlement is reached with all the drug companies. Plaintiffs’ attorneys had proposed the novel arrangement to bolster the chances of a sweeping settlement.

Polster called the creation of this negotiation class a “powerful, creative and helpful” option and reiterated that he hopes it leads to a settlement that would “expedite relief to communities so they can better address this devastating national health crisis.”

Although the state cases are not in Polster’s jurisdiction, he has urged a broad settlement that includes them.

“There’s an incredible incentive to make a deal before bankruptcy, because that would make the process much less expensive for the states and cities,” said Adam Zimmerman, a professor at Loyola Law School in Los Angeles. If Purdue sought bankruptcy protection without a settlement, “we might see any kind of arrangement tied up in bankruptcy court for a very long time.” “It could be years,” he added.

Asked a federal appeals court to delay or halt the federal trial

Yost, who wants the states to control the legal effort against the pharmaceutical industry, has asked a federal appeals court to delay or halt the federal trial. Another 13 states and the District of Columbia have filed briefs in support of that effort, according to Yost’s office.

Yost criticized using two Ohio counties as “bellwether” cases, saying they represent only a tiny portion of the state’s 88 counties.

“The rest of Ohio — and Ohio itself — is being left behind in the MDL lawsuit in Cleveland,” he said in a statement late last month. “The hardest-hit counties of Appalachia and the vast majority of the state are being asked to take a number and wait — and that wait could delay or prevent justice.”

Zimmerman characterized the conflict as a struggle for control of the legal process.

Zimmerman characterized the conflict as a struggle for control of the legal process.

“I think the main motivation [for Yost] has to do with who holds the balance of power with respect to negotiating a global settlement,” he said. “This is kind of a Hail Mary.”

Tentative deal reached with Purdue Pharma

A successful guide that uses anecdotes to reveal powerful truths about life.” – Kirkus Reviews

Buy What Goes Around at Amazon

“I’ve read a number of books that focus on a similar message and I find Rob’s to be my favorite.” – Sheryl Woodhouse, founder of Livelihood Matters LLC

Tentative deal reached with Purdue Pharma

Tentative deal reached with Purdue Pharma